Inflection Point Acquisition Corp. V
Inflection Point Acquisition Corp. V (IPEXR) Stock Competitors & Peer Comparison
See (IPEXR) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Conglomerates Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IPEXR | $0.53 | -8.66% | 175.4M | N/A | N/A | N/A |
| TPGXL | $24.37 | -0.20% | 23B | N/A | N/A | +5.25% |
| VOYA-PB | $23.13 | -0.94% | 7B | 2.74 | $8.44 | +2.77% |
| VOYA | $66.20 | -3.83% | 6.3B | 10.58 | $6.26 | +2.77% |
| BIPH | $15.94 | +0.95% | 5.7B | N/A | N/A | +7.93% |
| PACS | $30.59 | -5.41% | 4.8B | 25.07 | $1.22 | N/A |
| MSDL | $14.01 | -2.91% | 1.2B | 10.01 | $1.40 | +14.25% |
| RILYK | $25.23 | +0.16% | 787.6M | N/A | N/A | N/A |
| RILYM | $25.11 | +0.00% | 753M | N/A | N/A | N/A |
| RILYN | $23.75 | -0.96% | 741.4M | N/A | N/A | N/A |
Stock Comparison
IPEXR vs TPGXL Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, TPGXL has a market cap of 23B. Regarding current trading prices, IPEXR is priced at $0.53, while TPGXL trades at $24.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TPGXL's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to TPGXL's ROE of +0.16%. Regarding short-term risk, IPEXR is less volatile compared to TPGXL. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check TPGXL's competition here
IPEXR vs VOYA-PB Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, VOYA-PB has a market cap of 7B. Regarding current trading prices, IPEXR is priced at $0.53, while VOYA-PB trades at $23.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas VOYA-PB's P/E ratio is 2.74. In terms of profitability, IPEXR's ROE is +0.02%, compared to VOYA-PB's ROE of +0.14%. Regarding short-term risk, IPEXR is less volatile compared to VOYA-PB. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check VOYA-PB's competition here
IPEXR vs VOYA Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, VOYA has a market cap of 6.3B. Regarding current trading prices, IPEXR is priced at $0.53, while VOYA trades at $66.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas VOYA's P/E ratio is 10.58. In terms of profitability, IPEXR's ROE is +0.02%, compared to VOYA's ROE of +0.14%. Regarding short-term risk, IPEXR is less volatile compared to VOYA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check VOYA's competition here
IPEXR vs BIPH Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BIPH has a market cap of 5.7B. Regarding current trading prices, IPEXR is priced at $0.53, while BIPH trades at $15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BIPH's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BIPH's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to BIPH. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BIPH's competition here
IPEXR vs PACS Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, PACS has a market cap of 4.8B. Regarding current trading prices, IPEXR is priced at $0.53, while PACS trades at $30.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PACS's P/E ratio is 25.07. In terms of profitability, IPEXR's ROE is +0.02%, compared to PACS's ROE of +0.23%. Regarding short-term risk, IPEXR is less volatile compared to PACS. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PACS's competition here
IPEXR vs MSDL Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, MSDL has a market cap of 1.2B. Regarding current trading prices, IPEXR is priced at $0.53, while MSDL trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MSDL's P/E ratio is 10.01. In terms of profitability, IPEXR's ROE is +0.02%, compared to MSDL's ROE of +0.07%. Regarding short-term risk, IPEXR is less volatile compared to MSDL. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check MSDL's competition here
IPEXR vs RILYK Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYK has a market cap of 787.6M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYK trades at $25.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYK's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYK's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYK. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYK's competition here
IPEXR vs RILYM Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYM has a market cap of 753M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYM trades at $25.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYM's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYM's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYM. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYM's competition here
IPEXR vs RILYN Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYN has a market cap of 741.4M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYN trades at $23.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYN's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYN. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYN's competition here
IPEXR vs RILYG Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYG has a market cap of 718.7M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYG trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYG's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYG's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYG. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYG's competition here
IPEXR vs TREE Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, TREE has a market cap of 578.1M. Regarding current trading prices, IPEXR is priced at $0.53, while TREE trades at $41.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TREE's P/E ratio is 3.87. In terms of profitability, IPEXR's ROE is +0.02%, compared to TREE's ROE of +0.94%. Regarding short-term risk, IPEXR is less volatile compared to TREE. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check TREE's competition here
IPEXR vs RILYO Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYO has a market cap of 573.5M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYO trades at $25.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYO's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYO's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYO. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYO's competition here
IPEXR vs RILYT Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYT has a market cap of 552.9M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYT trades at $17.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYT's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYT's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYT. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYT's competition here
IPEXR vs BBCQW Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BBCQW has a market cap of 529M. Regarding current trading prices, IPEXR is priced at $0.53, while BBCQW trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BBCQW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BBCQW's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to BBCQW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BBCQW's competition here
IPEXR vs NWAX Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, NWAX has a market cap of 499.5M. Regarding current trading prices, IPEXR is priced at $0.53, while NWAX trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas NWAX's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to NWAX's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to NWAX. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check NWAX's competition here
IPEXR vs CRAN Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, CRAN has a market cap of 464.8M. Regarding current trading prices, IPEXR is priced at $0.53, while CRAN trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CRAN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CRAN's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to CRAN. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check CRAN's competition here
IPEXR vs CCXIU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, CCXIU has a market cap of 428.9M. Regarding current trading prices, IPEXR is priced at $0.53, while CCXIU trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CCXIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CCXIU's ROE of +0.00%. Regarding short-term risk, IPEXR and CCXIU have similar daily volatility (0.00).Check CCXIU's competition here
IPEXR vs MESH Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, MESH has a market cap of 426.3M. Regarding current trading prices, IPEXR is priced at $0.53, while MESH trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MESH's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MESH's ROE of N/A. Regarding short-term risk, IPEXR and MESH have similar daily volatility (0.00).Check MESH's competition here
IPEXR vs CCXI Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, CCXI has a market cap of 424.9M. Regarding current trading prices, IPEXR is priced at $0.53, while CCXI trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CCXI's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CCXI's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to CCXI. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check CCXI's competition here
IPEXR vs AACI Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, AACI has a market cap of 406.5M. Regarding current trading prices, IPEXR is priced at $0.53, while AACI trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas AACI's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to AACI's ROE of +0.02%. Regarding short-term risk, IPEXR is less volatile compared to AACI. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check AACI's competition here
IPEXR vs PLMKW Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, PLMKW has a market cap of 385.6M. Regarding current trading prices, IPEXR is priced at $0.53, while PLMKW trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PLMKW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PLMKW's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to PLMKW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PLMKW's competition here
IPEXR vs BBCQ Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BBCQ has a market cap of 383.7M. Regarding current trading prices, IPEXR is priced at $0.53, while BBCQ trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BBCQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BBCQ's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to BBCQ. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BBCQ's competition here
IPEXR vs ANSCU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ANSCU has a market cap of 383M. Regarding current trading prices, IPEXR is priced at $0.53, while ANSCU trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ANSCU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ANSCU's ROE of +0.03%. Regarding short-term risk, IPEXR and ANSCU have similar daily volatility (0.00).Check ANSCU's competition here
IPEXR vs DBCAU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, DBCAU has a market cap of 379.9M. Regarding current trading prices, IPEXR is priced at $0.53, while DBCAU trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DBCAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DBCAU's ROE of N/A. Regarding short-term risk, IPEXR and DBCAU have similar daily volatility (0.00).Check DBCAU's competition here
IPEXR vs RILYL Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYL has a market cap of 368.5M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYL trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYL's P/E ratio is 2.01. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYL's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYL. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYL's competition here
IPEXR vs NWAX-UN Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, NWAX-UN has a market cap of 361.5M. Regarding current trading prices, IPEXR is priced at $0.53, while NWAX-UN trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas NWAX-UN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to NWAX-UN's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to NWAX-UN. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check NWAX-UN's competition here
IPEXR vs CRANU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, CRANU has a market cap of 357.5M. Regarding current trading prices, IPEXR is priced at $0.53, while CRANU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CRANU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CRANU's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to CRANU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check CRANU's competition here
IPEXR vs RILYP Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILYP has a market cap of 350.8M. Regarding current trading prices, IPEXR is priced at $0.53, while RILYP trades at $11.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILYP's P/E ratio is 1.91. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILYP's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILYP. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILYP's competition here
IPEXR vs POLEU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, POLEU has a market cap of 345.9M. Regarding current trading prices, IPEXR is priced at $0.53, while POLEU trades at $11.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas POLEU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to POLEU's ROE of +0.05%. Regarding short-term risk, IPEXR and POLEU have similar daily volatility (0.00).Check POLEU's competition here
IPEXR vs SBXE Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SBXE has a market cap of 344.2M. Regarding current trading prices, IPEXR is priced at $0.53, while SBXE trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SBXE's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SBXE's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to SBXE. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SBXE's competition here
IPEXR vs DSAC Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, DSAC has a market cap of 340.4M. Regarding current trading prices, IPEXR is priced at $0.53, while DSAC trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DSAC's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DSAC's ROE of +0.11%. Regarding short-term risk, IPEXR is less volatile compared to DSAC. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DSAC's competition here
IPEXR vs ARCI Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ARCI has a market cap of 337.8M. Regarding current trading prices, IPEXR is priced at $0.53, while ARCI trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ARCI's P/E ratio is -4282.61. In terms of profitability, IPEXR's ROE is +0.02%, compared to ARCI's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to ARCI. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ARCI's competition here
IPEXR vs SAC Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SAC has a market cap of 312.4M. Regarding current trading prices, IPEXR is priced at $0.53, while SAC trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SAC's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SAC's ROE of +0.00%. Regarding short-term risk, IPEXR and SAC have similar daily volatility (0.00).Check SAC's competition here
IPEXR vs KBONU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, KBONU has a market cap of 306M. Regarding current trading prices, IPEXR is priced at $0.53, while KBONU trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas KBONU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to KBONU's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to KBONU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check KBONU's competition here
IPEXR vs DBCA Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, DBCA has a market cap of 305.2M. Regarding current trading prices, IPEXR is priced at $0.53, while DBCA trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DBCA's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DBCA's ROE of N/A. Regarding short-term risk, IPEXR and DBCA have similar daily volatility (0.00).Check DBCA's competition here
IPEXR vs ALOVU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ALOVU has a market cap of 298.6M. Regarding current trading prices, IPEXR is priced at $0.53, while ALOVU trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ALOVU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ALOVU's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to ALOVU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ALOVU's competition here
IPEXR vs PLMKU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, PLMKU has a market cap of 293.9M. Regarding current trading prices, IPEXR is priced at $0.53, while PLMKU trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PLMKU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PLMKU's ROE of +0.03%. Regarding short-term risk, IPEXR and PLMKU have similar daily volatility (0.00).Check PLMKU's competition here
IPEXR vs PTOR Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, PTOR has a market cap of 291.1M. Regarding current trading prices, IPEXR is priced at $0.53, while PTOR trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PTOR's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PTOR's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to PTOR. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PTOR's competition here
IPEXR vs BEAGU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BEAGU has a market cap of 282.4M. Regarding current trading prices, IPEXR is priced at $0.53, while BEAGU trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BEAGU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BEAGU's ROE of +0.05%. Regarding short-term risk, IPEXR and BEAGU have similar daily volatility (0.00).Check BEAGU's competition here
IPEXR vs XCBE Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, XCBE has a market cap of 277.7M. Regarding current trading prices, IPEXR is priced at $0.53, while XCBE trades at $9.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas XCBE's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to XCBE's ROE of +0.00%. Regarding short-term risk, IPEXR and XCBE have similar daily volatility (0.00).Check XCBE's competition here
IPEXR vs HVIIU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, HVIIU has a market cap of 273.8M. Regarding current trading prices, IPEXR is priced at $0.53, while HVIIU trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HVIIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to HVIIU's ROE of +0.02%. Regarding short-term risk, IPEXR and HVIIU have similar daily volatility (0.00).Check HVIIU's competition here
IPEXR vs XSLL Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, XSLL has a market cap of 272.6M. Regarding current trading prices, IPEXR is priced at $0.53, while XSLL trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas XSLL's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to XSLL's ROE of +0.00%. Regarding short-term risk, IPEXR and XSLL have similar daily volatility (0.00).Check XSLL's competition here
IPEXR vs HVII Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, HVII has a market cap of 269.1M. Regarding current trading prices, IPEXR is priced at $0.53, while HVII trades at $10.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HVII's P/E ratio is 68.93. In terms of profitability, IPEXR's ROE is +0.02%, compared to HVII's ROE of +0.02%. Regarding short-term risk, IPEXR and HVII have similar daily volatility (0.00).Check HVII's competition here
IPEXR vs FACTU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, FACTU has a market cap of 265.2M. Regarding current trading prices, IPEXR is priced at $0.53, while FACTU trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas FACTU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to FACTU's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to FACTU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check FACTU's competition here
IPEXR vs SORN Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SORN has a market cap of 260.4M. Regarding current trading prices, IPEXR is priced at $0.53, while SORN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SORN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SORN's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to SORN. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SORN's competition here
IPEXR vs ALOV Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ALOV has a market cap of 258.1M. Regarding current trading prices, IPEXR is priced at $0.53, while ALOV trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ALOV's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ALOV's ROE of N/A. Regarding short-term risk, IPEXR and ALOV have similar daily volatility (0.00).Check ALOV's competition here
IPEXR vs PLMK Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, PLMK has a market cap of 256M. Regarding current trading prices, IPEXR is priced at $0.53, while PLMK trades at $10.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PLMK's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PLMK's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to PLMK. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PLMK's competition here
IPEXR vs ACAAU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ACAAU has a market cap of 252M. Regarding current trading prices, IPEXR is priced at $0.53, while ACAAU trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ACAAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ACAAU's ROE of +0.00%. Regarding short-term risk, IPEXR and ACAAU have similar daily volatility (0.00).Check ACAAU's competition here
IPEXR vs OIMAW Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, OIMAW has a market cap of 250M. Regarding current trading prices, IPEXR is priced at $0.53, while OIMAW trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas OIMAW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to OIMAW's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to OIMAW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check OIMAW's competition here
IPEXR vs HCICU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, HCICU has a market cap of 248.2M. Regarding current trading prices, IPEXR is priced at $0.53, while HCICU trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas HCICU's P/E ratio is 42.92. In terms of profitability, IPEXR's ROE is +0.02%, compared to HCICU's ROE of -0.78%. Regarding short-term risk, IPEXR and HCICU have similar daily volatility (0.00).Check HCICU's competition here
IPEXR vs DMAAU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, DMAAU has a market cap of 246M. Regarding current trading prices, IPEXR is priced at $0.53, while DMAAU trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DMAAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DMAAU's ROE of +0.03%. Regarding short-term risk, IPEXR and DMAAU have similar daily volatility (0.00).Check DMAAU's competition here
IPEXR vs SBXE-UN Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SBXE-UN has a market cap of 241.9M. Regarding current trading prices, IPEXR is priced at $0.53, while SBXE-UN trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SBXE-UN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SBXE-UN's ROE of -0.06%. Regarding short-term risk, IPEXR and SBXE-UN have similar daily volatility (0.00).Check SBXE-UN's competition here
IPEXR vs DRDB Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, DRDB has a market cap of 240.9M. Regarding current trading prices, IPEXR is priced at $0.53, while DRDB trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DRDB's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DRDB's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to DRDB. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DRDB's competition here
IPEXR vs APLMW Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, APLMW has a market cap of 238M. Regarding current trading prices, IPEXR is priced at $0.53, while APLMW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas APLMW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to APLMW's ROE of -133.85%. Regarding short-term risk, IPEXR is less volatile compared to APLMW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check APLMW's competition here
IPEXR vs IRHO Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, IRHO has a market cap of 232.2M. Regarding current trading prices, IPEXR is priced at $0.53, while IRHO trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas IRHO's P/E ratio is -985.00. In terms of profitability, IPEXR's ROE is +0.02%, compared to IRHO's ROE of +1.87%. Regarding short-term risk, IPEXR is less volatile compared to IRHO. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check IRHO's competition here
IPEXR vs SAAQ Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SAAQ has a market cap of 229.3M. Regarding current trading prices, IPEXR is priced at $0.53, while SAAQ trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SAAQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SAAQ's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to SAAQ. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SAAQ's competition here
IPEXR vs VHCP Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, VHCP has a market cap of 228.4M. Regarding current trading prices, IPEXR is priced at $0.53, while VHCP trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas VHCP's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to VHCP's ROE of N/A. Regarding short-term risk, IPEXR and VHCP have similar daily volatility (0.00).Check VHCP's competition here
IPEXR vs BLRK Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BLRK has a market cap of 227.9M. Regarding current trading prices, IPEXR is priced at $0.53, while BLRK trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BLRK's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BLRK's ROE of N/A. Regarding short-term risk, IPEXR and BLRK have similar daily volatility (0.00).Check BLRK's competition here
IPEXR vs ADAC Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ADAC has a market cap of 227.7M. Regarding current trading prices, IPEXR is priced at $0.53, while ADAC trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ADAC's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ADAC's ROE of +0.00%. Regarding short-term risk, IPEXR and ADAC have similar daily volatility (0.00).Check ADAC's competition here
IPEXR vs LPCV Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, LPCV has a market cap of 227.7M. Regarding current trading prices, IPEXR is priced at $0.53, while LPCV trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas LPCV's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to LPCV's ROE of N/A. Regarding short-term risk, IPEXR and LPCV have similar daily volatility (0.00).Check LPCV's competition here
IPEXR vs BIII Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BIII has a market cap of 227M. Regarding current trading prices, IPEXR is priced at $0.53, while BIII trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BIII's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BIII's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to BIII. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check BIII's competition here
IPEXR vs MEVOU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, MEVOU has a market cap of 226.1M. Regarding current trading prices, IPEXR is priced at $0.53, while MEVOU trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MEVOU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MEVOU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to MEVOU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check MEVOU's competition here
IPEXR vs GIXXU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, GIXXU has a market cap of 224.6M. Regarding current trading prices, IPEXR is priced at $0.53, while GIXXU trades at $10.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas GIXXU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to GIXXU's ROE of +0.00%. Regarding short-term risk, IPEXR and GIXXU have similar daily volatility (0.00).Check GIXXU's competition here
IPEXR vs SVAQ Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SVAQ has a market cap of 218.9M. Regarding current trading prices, IPEXR is priced at $0.53, while SVAQ trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SVAQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SVAQ's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to SVAQ. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SVAQ's competition here
IPEXR vs PTORU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, PTORU has a market cap of 217.8M. Regarding current trading prices, IPEXR is priced at $0.53, while PTORU trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas PTORU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to PTORU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to PTORU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check PTORU's competition here
IPEXR vs RILY Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RILY has a market cap of 212M. Regarding current trading prices, IPEXR is priced at $0.53, while RILY trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RILY's P/E ratio is -2.29. In terms of profitability, IPEXR's ROE is +0.02%, compared to RILY's ROE of -0.71%. Regarding short-term risk, IPEXR is less volatile compared to RILY. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RILY's competition here
IPEXR vs SSACU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SSACU has a market cap of 211.7M. Regarding current trading prices, IPEXR is priced at $0.53, while SSACU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SSACU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SSACU's ROE of +0.00%. Regarding short-term risk, IPEXR and SSACU have similar daily volatility (0.00).Check SSACU's competition here
IPEXR vs DRDBU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, DRDBU has a market cap of 210.6M. Regarding current trading prices, IPEXR is priced at $0.53, while DRDBU trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DRDBU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to DRDBU's ROE of +0.03%. Regarding short-term risk, IPEXR is less volatile compared to DRDBU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DRDBU's competition here
IPEXR vs SAC-UN Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SAC-UN has a market cap of 202.2M. Regarding current trading prices, IPEXR is priced at $0.53, while SAC-UN trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SAC-UN's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SAC-UN's ROE of N/A. Regarding short-term risk, IPEXR and SAC-UN have similar daily volatility (0.00).Check SAC-UN's competition here
IPEXR vs TRGSU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, TRGSU has a market cap of 199.6M. Regarding current trading prices, IPEXR is priced at $0.53, while TRGSU trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TRGSU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to TRGSU's ROE of N/A. Regarding short-term risk, IPEXR and TRGSU have similar daily volatility (0.00).Check TRGSU's competition here
IPEXR vs XCBEU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, XCBEU has a market cap of 199.2M. Regarding current trading prices, IPEXR is priced at $0.53, while XCBEU trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas XCBEU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to XCBEU's ROE of N/A. Regarding short-term risk, IPEXR and XCBEU have similar daily volatility (0.00).Check XCBEU's competition here
IPEXR vs NTWOU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, NTWOU has a market cap of 189.9M. Regarding current trading prices, IPEXR is priced at $0.53, while NTWOU trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas NTWOU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to NTWOU's ROE of +0.04%. Regarding short-term risk, IPEXR and NTWOU have similar daily volatility (0.00).Check NTWOU's competition here
IPEXR vs MUZEU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, MUZEU has a market cap of 178.4M. Regarding current trading prices, IPEXR is priced at $0.53, while MUZEU trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MUZEU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MUZEU's ROE of N/A. Regarding short-term risk, IPEXR and MUZEU have similar daily volatility (0.00).Check MUZEU's competition here
IPEXR vs SCII Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SCII has a market cap of 174.9M. Regarding current trading prices, IPEXR is priced at $0.53, while SCII trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SCII's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SCII's ROE of N/A. Regarding short-term risk, IPEXR and SCII have similar daily volatility (0.00).Check SCII's competition here
IPEXR vs ETHM Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ETHM has a market cap of 173.8M. Regarding current trading prices, IPEXR is priced at $0.53, while ETHM trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ETHM's P/E ratio is -13.09. In terms of profitability, IPEXR's ROE is +0.02%, compared to ETHM's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to ETHM. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ETHM's competition here
IPEXR vs RANG Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RANG has a market cap of 168.7M. Regarding current trading prices, IPEXR is priced at $0.53, while RANG trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RANG's P/E ratio is 42.08. In terms of profitability, IPEXR's ROE is +0.02%, compared to RANG's ROE of +0.03%. Regarding short-term risk, IPEXR and RANG have similar daily volatility (0.00).Check RANG's competition here
IPEXR vs IRAB Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, IRAB has a market cap of 167.8M. Regarding current trading prices, IPEXR is priced at $0.53, while IRAB trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas IRAB's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to IRAB's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to IRAB. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check IRAB's competition here
IPEXR vs SVCCU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SVCCU has a market cap of 164.1M. Regarding current trading prices, IPEXR is priced at $0.53, while SVCCU trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SVCCU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SVCCU's ROE of +0.05%. Regarding short-term risk, IPEXR and SVCCU have similar daily volatility (0.00).Check SVCCU's competition here
IPEXR vs TAVIU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, TAVIU has a market cap of 162.2M. Regarding current trading prices, IPEXR is priced at $0.53, while TAVIU trades at $11.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TAVIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to TAVIU's ROE of +0.04%. Regarding short-term risk, IPEXR and TAVIU have similar daily volatility (0.00).Check TAVIU's competition here
IPEXR vs CTAAU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, CTAAU has a market cap of 153.2M. Regarding current trading prices, IPEXR is priced at $0.53, while CTAAU trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CTAAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CTAAU's ROE of N/A. Regarding short-term risk, IPEXR and CTAAU have similar daily volatility (0.00).Check CTAAU's competition here
IPEXR vs BSIIU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BSIIU has a market cap of 152.8M. Regarding current trading prices, IPEXR is priced at $0.53, while BSIIU trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BSIIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BSIIU's ROE of +0.02%. Regarding short-term risk, IPEXR and BSIIU have similar daily volatility (0.00).Check BSIIU's competition here
IPEXR vs SUMAU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SUMAU has a market cap of 150.2M. Regarding current trading prices, IPEXR is priced at $0.53, while SUMAU trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SUMAU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SUMAU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to SUMAU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SUMAU's competition here
IPEXR vs TDWD Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, TDWD has a market cap of 149.1M. Regarding current trading prices, IPEXR is priced at $0.53, while TDWD trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas TDWD's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to TDWD's ROE of +0.00%. Regarding short-term risk, IPEXR and TDWD have similar daily volatility (0.00).Check TDWD's competition here
IPEXR vs SORNW Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SORNW has a market cap of 135.7M. Regarding current trading prices, IPEXR is priced at $0.53, while SORNW trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SORNW's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SORNW's ROE of +0.00%. Regarding short-term risk, IPEXR is less volatile compared to SORNW. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SORNW's competition here
IPEXR vs SCPQ Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SCPQ has a market cap of 135.5M. Regarding current trading prices, IPEXR is priced at $0.53, while SCPQ trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SCPQ's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SCPQ's ROE of N/A. Regarding short-term risk, IPEXR and SCPQ have similar daily volatility (0.00).Check SCPQ's competition here
IPEXR vs SPHA Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, SPHA has a market cap of 111.7M. Regarding current trading prices, IPEXR is priced at $0.53, while SPHA trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas SPHA's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to SPHA's ROE of -2.76%. Regarding short-term risk, IPEXR is less volatile compared to SPHA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check SPHA's competition here
IPEXR vs CHPG Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, CHPG has a market cap of 103M. Regarding current trading prices, IPEXR is priced at $0.53, while CHPG trades at $10.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CHPG's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CHPG's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to CHPG. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check CHPG's competition here
IPEXR vs RFAMU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RFAMU has a market cap of 102.6M. Regarding current trading prices, IPEXR is priced at $0.53, while RFAMU trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RFAMU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to RFAMU's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to RFAMU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RFAMU's competition here
IPEXR vs BHAVU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, BHAVU has a market cap of 101.6M. Regarding current trading prices, IPEXR is priced at $0.53, while BHAVU trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas BHAVU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to BHAVU's ROE of +0.00%. Regarding short-term risk, IPEXR and BHAVU have similar daily volatility (0.00).Check BHAVU's competition here
IPEXR vs NOEM Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, NOEM has a market cap of 99.4M. Regarding current trading prices, IPEXR is priced at $0.53, while NOEM trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas NOEM's P/E ratio is 61.00. In terms of profitability, IPEXR's ROE is +0.02%, compared to NOEM's ROE of +0.02%. Regarding short-term risk, IPEXR and NOEM have similar daily volatility (0.00).Check NOEM's competition here
IPEXR vs DTSQ Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, DTSQ has a market cap of 98.2M. Regarding current trading prices, IPEXR is priced at $0.53, while DTSQ trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas DTSQ's P/E ratio is 34.47. In terms of profitability, IPEXR's ROE is +0.02%, compared to DTSQ's ROE of +0.04%. Regarding short-term risk, IPEXR is less volatile compared to DTSQ. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check DTSQ's competition here
IPEXR vs RMI Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, RMI has a market cap of 94.1M. Regarding current trading prices, IPEXR is priced at $0.53, while RMI trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas RMI's P/E ratio is 123.00. In terms of profitability, IPEXR's ROE is +0.02%, compared to RMI's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to RMI. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check RMI's competition here
IPEXR vs CAPNU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, CAPNU has a market cap of 94M. Regarding current trading prices, IPEXR is priced at $0.53, while CAPNU trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas CAPNU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to CAPNU's ROE of +0.04%. Regarding short-term risk, IPEXR and CAPNU have similar daily volatility (0.00).Check CAPNU's competition here
IPEXR vs MMTX Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, MMTX has a market cap of 88.2M. Regarding current trading prices, IPEXR is priced at $0.53, while MMTX trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas MMTX's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to MMTX's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to MMTX. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check MMTX's competition here
IPEXR vs FLDD Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, FLDD has a market cap of 85.6M. Regarding current trading prices, IPEXR is priced at $0.53, while FLDD trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas FLDD's P/E ratio is -75.13. In terms of profitability, IPEXR's ROE is +0.02%, compared to FLDD's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to FLDD. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check FLDD's competition here
IPEXR vs YHNA Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, YHNA has a market cap of 83.1M. Regarding current trading prices, IPEXR is priced at $0.53, while YHNA trades at $10.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas YHNA's P/E ratio is 35.73. In terms of profitability, IPEXR's ROE is +0.02%, compared to YHNA's ROE of +0.03%. Regarding short-term risk, IPEXR and YHNA have similar daily volatility (0.00).Check YHNA's competition here
IPEXR vs ACOG Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ACOG has a market cap of 75.6M. Regarding current trading prices, IPEXR is priced at $0.53, while ACOG trades at $5.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ACOG's P/E ratio is -3.69. In terms of profitability, IPEXR's ROE is +0.02%, compared to ACOG's ROE of -0.49%. Regarding short-term risk, IPEXR is less volatile compared to ACOG. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ACOG's competition here
IPEXR vs ITHA Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, ITHA has a market cap of 75.1M. Regarding current trading prices, IPEXR is priced at $0.53, while ITHA trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas ITHA's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to ITHA's ROE of N/A. Regarding short-term risk, IPEXR is less volatile compared to ITHA. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check ITHA's competition here
IPEXR vs AACIU Comparison March 2026
IPEXR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPEXR stands at 175.4M. In comparison, AACIU has a market cap of 71.5M. Regarding current trading prices, IPEXR is priced at $0.53, while AACIU trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPEXR currently has a P/E ratio of N/A, whereas AACIU's P/E ratio is N/A. In terms of profitability, IPEXR's ROE is +0.02%, compared to AACIU's ROE of +0.01%. Regarding short-term risk, IPEXR is less volatile compared to AACIU. This indicates potentially lower risk in terms of short-term price fluctuations for IPEXR.Check AACIU's competition here